<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03533322</url>
  </required_header>
  <id_info>
    <org_study_id>gallbladderstatusinchhemlytic</org_study_id>
    <nct_id>NCT03533322</nct_id>
  </id_info>
  <brief_title>Gall Bladder Status Among Children With Chronic Haemolytic Anemia</brief_title>
  <acronym>GBSACWCHA</acronym>
  <official_title>Gall Bladder Status Among Children With Chronic Haemolytic Anemia Attending to Assuit University Children Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gall bladder status among children with chronic haemolytic anemia attending to Assuit&#xD;
      University Children Hospital.&#xD;
&#xD;
      Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC&#xD;
      life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to&#xD;
      produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus,&#xD;
      approximately 0.85% of the most senescent RBCs are removed and replaced each day.&#xD;
&#xD;
      Patients with chronic haemolytic anemia are subjected to many complications of chronic&#xD;
      haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis&#xD;
      and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone&#xD;
      formation.&#xD;
&#xD;
      This work aims to a) to determine the prevalence of gall bladder diseases among patient with&#xD;
      chronic haemolytic anemia.&#xD;
&#xD;
      b) to determine the risk factors of gall bladder diseases among patients with chronic&#xD;
      haemolytic anemia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gall bladder status among children with chronic haemolytic anemia attending to Assuit&#xD;
      University Children Hospital Hemolysis is defined as the premature destruction of red blood&#xD;
      cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds&#xD;
      the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days&#xD;
      (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed&#xD;
      and replaced each day.(1) They may be classified according to the means of hemolysis, being&#xD;
      either intrinsic in cases where the cause is related to the red blood cell (RBC) itself,&#xD;
      defects of red blood cell membrane production (as in hereditary spherocytosis and hereditary&#xD;
      elliptocytosis), defects in hemoglobin production (as in thalassemia, sickle-cell disease and&#xD;
      congenital dyserythropoietic anemia), defective red cell metabolism (as in&#xD;
      glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency). or extrinsic in&#xD;
      cases where factors external to the RBC dominate, acquired hemolytic anemia may be caused by&#xD;
      immune-mediated causes, drugs and other miscellaneous causes. Patients with chronic&#xD;
      haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic&#xD;
      heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism,&#xD;
      haemosiderosis ,among them there is incidence of gallbladder stone formation.(2) The&#xD;
      gallbladder is a small pouch that sits just under the liver. The gallbladder stores bile&#xD;
      produced by the liver. After meals, the gallbladder is empty and flat, like a deflated&#xD;
      balloon. Before a meal, the gallbladder may be full of bile and about the size of a small&#xD;
      pear. In response to signals, the gallbladder squeezes stored bile into the small intestine&#xD;
      through a series of tubes called ducts. Bile helps digest fat.(3) Diseases affecting gall&#xD;
      bladder in children as:a)Gallstones (cholelithiasis) for unclear reasons, substances in bile&#xD;
      can crystallize in the gallbladder, forming gallstones which is common and usually harmless,&#xD;
      gallstones can sometimes cause pain, nausea, or inflammation. b)Cholecystitis( Infection of&#xD;
      the gallbladder), often due to a gallstone in the gallbladder. Cholecystitis causes severe&#xD;
      pain and fever, and can require surgery when infection continues or recurs.c) Gallstone&#xD;
      pancreatitis: An impacted gallstone blocks the ducts that drain the pancreas. Inflammation of&#xD;
      the pancreas results, a serious condition.(4) While problems associated with the gallbladder&#xD;
      are rare in children, almost 50 percent of children have gallstones. Many of them--between 80&#xD;
      percent and 90 percent--have no symptoms. However, even small stones in small children can&#xD;
      cause problems , Gallstones are mainly categorized in three groups of cholesterol, pigment,&#xD;
      and mixture, among which the mixture is more common. Imbalance in bile constituents,such as&#xD;
      cholesterol,lecithin,andbilesalts,is the main cause of gallstone formation.(4-5) In children&#xD;
      &gt;70% of gallstones are the pigment type, these stones are mostly reported in cases with&#xD;
      hemolytic disease, such as spherocytosis and sickle cell anemia, cirrhosis, bile tract&#xD;
      infection, these stones are black-brown in color, the incidence increases progressively with&#xD;
      age. In sickle-cell disease, the prevalence of pigment gallstones( was reported to be 10% to&#xD;
      15% in children under 10 years of age, it increased to 40% in those aged 10-18 years, and 50%&#xD;
      in adults(6-7). The prevalence of gallstones in hereditary spherocytosis was 10% to 20% and&#xD;
      in adult series it was 40%(7-8). In thalassemia, the reported figure is low (10% to&#xD;
      15%)(8-9). With longer survival of thalassemiapatients, higher prevalence of gallstones (50%)&#xD;
      has been reported(9). The highest prevalence of gallstones have been reported in thalassemics&#xD;
      with Gilbert's syndrome genotype(10). However, in a study on 64 patients with median age of&#xD;
      10 (range, 5 to 20) years with thalassemia major from Chandigarh, none had gallstones(11).&#xD;
&#xD;
      Risk factors&#xD;
&#xD;
        1. Multiple blood transfusions: In patients who periodically receive blood transfusions,&#xD;
           hemolysis of the transfused cells may supplement the chronic endogenous blood&#xD;
           destruction as a factor in the formation of gallstones [11-12].&#xD;
&#xD;
        2. High rates (20% by age of four years) of recurrent biliary tract obstruction in children&#xD;
           with the sickle cell disease reported [13].&#xD;
&#xD;
        3. Obesity: With the prevalence of childhood obesity on the rise, there is a need to be&#xD;
           more aware of obesity-related comorbidity including gallbladder disease. No clear link&#xD;
           between the diet and risk for cholelithiasis, though foods high in cholesterol and low&#xD;
           in fiber may increase the risk [14].&#xD;
&#xD;
        4. Inefficient and infrequent gallbladder contractions, which allow bile to sit in the&#xD;
           gallbladder for long periods of time, resulting in an over concentrated bile that is&#xD;
           conducive to stone formation [15].&#xD;
&#xD;
      1-Aim of the study:&#xD;
&#xD;
        1. to determine the prevalence of gall bladder diseases among patient with chronic&#xD;
           haemolytic anemia.&#xD;
&#xD;
        2. to determine the risk factors of gall bladder diseases among patients with chronic&#xD;
           haemolytic anemia.&#xD;
&#xD;
           2-Patients and methods: All cases included in the study will be subjected to:&#xD;
&#xD;
             -  Full clinical history including (age of onset of chronic haemolytic anemia- type of&#xD;
                chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea -&#xD;
                splenectomy or not- frequency of admission)&#xD;
&#xD;
             -  Detailed clinical examination&#xD;
&#xD;
             -  Abdominal ultrasound&#xD;
&#xD;
             -  Plain KUB (kidney ureter bladder) x-ray if radiopaque stone.&#xD;
&#xD;
             -  Compelete blood count&#xD;
&#xD;
             -  Liver function test&#xD;
&#xD;
             -  C- reactive protein&#xD;
&#xD;
           Type of study: cross- sectional study&#xD;
&#xD;
           Site of the study: Haematology ;general surgery units and out patient clinics ;emergency&#xD;
           unit at Assuit university children hospital.&#xD;
&#xD;
           Duration of the study: one year&#xD;
&#xD;
           Inclusion crieteria: children between 1 :18 years known to have chronic haemolytic&#xD;
           anemia.&#xD;
&#xD;
           Exclusion crieteria:&#xD;
&#xD;
           children below 1 year and above 18 years children had past history of cholecystectomy&#xD;
&#xD;
           Data analysis : Data will be processed and analyzed using SPSS software and the results&#xD;
           will be processed in tables and figures .&#xD;
&#xD;
           Ethical consideration:&#xD;
&#xD;
             -  Reviewing the proposal will be carried out before starting via the ethical&#xD;
                committee of assuit faculty of medicine.&#xD;
&#xD;
             -  The aim of the study will be explained to each patient before beginning of the&#xD;
                process,written consent will be obtained from those who welcome to participate in&#xD;
                the study.&#xD;
&#xD;
             -  Privacy and confidentiality of all data will be assur&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prevelance of gall bladder diseases in children with chronic hemolytic syndrome</measure>
    <time_frame>one year</time_frame>
    <description>gall bladder diseases</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Gall Bladder Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted to Assiut university children Hospital 1 year study&#xD;
&#xD;
          -  2.4.4 -Study tools (in detail, e.g., lab methods, instruments, steps, chemicals, â€¦):&#xD;
             Full clinical history including (age of onset of chronic haemolytic anemia- type of&#xD;
             chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea -&#xD;
             splenectomy or not- frequency of admission)&#xD;
&#xD;
          -  Detailed clinical examination&#xD;
&#xD;
          -  Abdominal ultrasound&#xD;
&#xD;
          -  Plain KUB (kidney ureter bladder) x-rayif radiopaque stone.&#xD;
&#xD;
          -  Compelete blood count&#xD;
&#xD;
          -  Liver function test&#xD;
&#xD;
          -  C- reactive protein&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children between 1 :18 years known to have chronic haemolytic anemia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  children below 1 year and above 18 years children had past history of cholecystectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>abelatif abdelmoez, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>assiut universitypediatric hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>shereen galal, assistprof</last_name>
    <role>Principal Investigator</role>
    <affiliation>assiut universitypediatric hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>shohnda nazeir, master</last_name>
    <phone>01064195028</phone>
    <email>shahdmohammed2060@gmail.com</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 11, 2018</study_first_submitted>
  <study_first_submitted_qc>May 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <last_update_submitted>July 29, 2018</last_update_submitted>
  <last_update_submitted_qc>July 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Shohnda Mohammed Nazeir</investigator_full_name>
    <investigator_title>Gall bladder status among children with chronic haemolytic anemia attending to Assiut University children hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallbladder Diseases</mesh_term>
    <mesh_term>Urinary Bladder Diseases</mesh_term>
    <mesh_term>Anemia, Hemolytic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

